Sabur Technology

Leadership

John F. Burd PhD

John F. Burd, PhD – Chief Executive Officer

Dr. Burd has over 30 years of experience in glucose monitoring technology. Dr. Burd was the founder of DexCom, where he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. DexCom has a market capitalization of more than $5 billion. Previously, Dr. Burd was CEO of Oculir, MiraMedica and LXN. Dr. Burd has authored and co-authored numerous articles and his work in the medical and biotechnology field has led to the filing and ownership of twenty-three patents and the development of many innovative medical products. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.
Michael Walsh

Michael Walsh – Chairman of the Board

Mr. Walsh has over 30 years of experience in the life sciences. Mr. Walsh founded Proprius Pharmaceuticals and was its President and CEO from its founding until it was acquired by Cypress Bioscience. Prior to establishing Proprius, Mr. Walsh was a founder and President, CEO, and Executive Chairman at Prometheus Laboratories, Inc., a specialty pharmaceutical company. Previously, Mr. Walsh held executive positions with Quidel and La Jolla Pharmaceutical Company. Mr. Walsh has a Bachelor of Science degree from the University of Notre Dame and an M.B.A. from Pepperdine University.
Michael Beeuwsaert

Michael Beeuwsaert – Chief Financial Officer

Mr. Beeuwsaert has over 25 years of experience as CEO or CFO in medical technology. He is a Partner at Novus Medical Ventures. Previously, he was Founder & CEO of Numira, a CRO with patented imaging technology. Prior to Numira, he served as CEO of Alerion, a life science tool company. Prior to that, Mr. Beeuwsaert was the CFO, then CEO at LXN, a company with innovative devices for controlling diabetes. After filing for an IPO, LXN was acquired by a market leader. Prior to LXN, he served as CFO at Ansys Diagnostics. Mr. Beeuwsaert received a BA in Accounting from California State University, Fullerton and an MBA from Pepperdine University.
Amy Rasdal

Amy Rasdal – Chief Operating Officer

Ms. Rasdal has over 25 years of experience in Operations, Product Development, Corporate Development and Marketing. Amy Rasdal started her own company, Rasdal Associates, Inc., 15 years ago. Rasdal Associates specializes in the other side of entrepreneurship - implementation and execution. Prior to forming Rasdal Associates, Ms. Rasdal held a variety of positions at CareFusion, Cardinal Health, Tandem Medical, Epic Cycle Interactive and ASK Computer Systems. Ms. Rasdal has an MBA from The Amos Tuck School at Dartmouth as well as undergraduate degrees in Computer Science, Music and French.
Dennis Sabo

Dennis Sabo – Vice-President of Marketing

Mr. Sabo has over 30 years of experience in the medical device industry. Mr. Sabo was Chief Operating Officer of Serim Research Corporation. Serim Research developed, manufactured and marketed a broad range of dry phase chemistry products to the dialysis, infection control and diagnostic marketplaces. Previously, Mr. Sabo was Senior Vice President in charge of worldwide operations for Bayer Corporation’s Near Patient Care Business Unit. Mr. Sabo also held various marketing and executive positions within Bayer for twenty-five years including seven years abroad. Mr. Sabo was educated at Bowling Green State University and Johns Hopkins University.
Dennis Sabo

Vivianne Noetzel – Vice President, Clinical and Regulatory Affairs

Ms. Noetzel has over 30 years of experience in the medical device industry. Ms. Noetzel was Vice President of Research and Clinical/Regulatory Affairs of LXN Corporation, Applied Biotech Corporation and held several management positions at Quidel Corporation. Vivianne Noetzel started her own company, Noetzel Terratech over 10 years ago. Noetzel Terratech specializes in Clinical/Regulatory Affairs and counts several local and international clients including Occulir, Inc., Qualigen, Inc., DexCom, Inc. Ms. Noetzel started as a bench scientist at the SALK Institute. Ms. Noetzel has a Bachelor of Arts Degree in Biochemistry as well as undergraduate degrees in Organic Chemistry and Spanish Literature from the University of California, San Diego. .
Copyright © 2018. Sabur Technology. All Rights Reserved.